Skip to main content

Table 3 Discharge on oral therapy criteria

From: A new approach to treatment of resistant gram-positive infections: potential impact of targeted IV to oral switch on length of stay

1. Clinical status • Afebrile for at least 48 hours
• Tolerates normal diet
• IV access only required for glycopeptide therapy
• Physically independent/well enough for residential/nursing home care
2. Clinical team discharge policy • A YES answer to the question: "If this patient was on an equally effective oral antibiotic, could they be discharged today?"